We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Light-Sensitive Nanoparticles Designed for Smart Drug Release

By LabMedica International staff writers
Posted on 14 Feb 2018
Image: Vials containing samples of \"hairy\" nanoparticles: the right and left vials contain photo-responsive polymer-capped gold nanoparticles prior to and after self-assembly, respectively. The center vial shows dye released from self-assembled gold nanoparticles. The nanoparticles were made with light-sensitive materials that assembled and disassembled themselves when exposed to light of different wavelengths (Photo courtesy of Rob Felt, Georgia Institute of Technology).
Image: Vials containing samples of \"hairy\" nanoparticles: the right and left vials contain photo-responsive polymer-capped gold nanoparticles prior to and after self-assembly, respectively. The center vial shows dye released from self-assembled gold nanoparticles. The nanoparticles were made with light-sensitive materials that assembled and disassembled themselves when exposed to light of different wavelengths (Photo courtesy of Rob Felt, Georgia Institute of Technology).
A novel type of "smart" nanoparticles responds to light of specific wavelengths that causes the particles to assemble or disassemble, which enables the dynamic organization of the nanoparticles for in vitro drug release.

The ability to dynamically organize functional nanoparticles (NPs) via the use of environmental triggers (temperature, pH, light, or solvent polarity) opens up important perspectives for rapid and convenient construction of a rich variety of complex assemblies and materials with new structures and functionalities.

In a study published in the January 31, 2018, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences, investigators at the Georgia Institute of Technology (Atlanta, USA) described an unconventional strategy for crafting stable "hairy" NPs with light-enabled reversible and reliable self-assembly and tunable optical properties.

The "hairy" nanoparticles were fabricated around a tiny core of beta-cyclodextrin from which polymer chains of poly(acrylicacid)-block-poly(7-methylacryloyloxy-4-methylcoumarin) (PAA-b-PMAMC) were grown. This compound attracted water-soluble metal precursors, which utilized the space within the polymer hairs as nano-reactors to form gold nanoparticles. The investigators then added hairs made from the light sensitive hydrophobic monomer MAMC.

Light at a wavelength of 365 nanometers induced the nanoparticles to self-assemble through a photo-dimerization process, while the process was reversed when the particles were exposed to light at 254 nanometers.

“Under light, the assemblies of photo-sensitive nanoparticles separate over a period of hours at a rate that can be controlled by the intensity and wavelength of the light,” said senior author Dr. Zhiqun Lin, professor of materials science and engineering at the Georgia Institute of Technology. “Because the disassembly can be turned on and off at will, we could provide a timed release of the drug by controlling the short-wavelength light exposure. Once the polymer chains from adjacent gold nanoparticles begin to photo-crosslink, they bring nanoparticles together via a self-assembly process to generate large assemblies of nanoparticles. This process is completely reversible and can be repeated in many cycles.”

“We envision that these photo-responsive polymer-capped gold nanoparticles could one day serve as nano-carriers for drug delivery into the body using our robust and reversible process for assembly and disassembly,” said Dr. Lin. “Used in cancer therapy, this process could increase the impact of a treatment by heating the cancer cells while introducing the drug compound into the tumor.”

Related Links:
Georgia Institute of Technology

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more